UA87851C2 - Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis - Google Patents

Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Info

Publication number
UA87851C2
UA87851C2 UAA200614053A UAA200614053A UA87851C2 UA 87851 C2 UA87851 C2 UA 87851C2 UA A200614053 A UAA200614053 A UA A200614053A UA A200614053 A UAA200614053 A UA A200614053A UA 87851 C2 UA87851 C2 UA 87851C2
Authority
UA
Ukraine
Prior art keywords
angiogenesis
diseases associated
proliferative disorders
derivatives useful
pyrrolotriazine derivatives
Prior art date
Application number
UAA200614053A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джулие А. Диксон
Катерине Бреннан
Карл Миранда
Брент Чандлер
Бартон Филлипс
Джианмеи Фан
Микхаель Брандс
Андреа Макклуре
Бенжамин Джонес
Венланг Фу
Доналд Биэрер
Стивен Магнусон
Гаролд С.Е. Клуендер
Original Assignee
Байер Фармасьютикалз Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Фармасьютикалз Корпорейшн filed Critical Байер Фармасьютикалз Корпорейшн
Publication of UA87851C2 publication Critical patent/UA87851C2/en

Links

Abstract

This invention relates to pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis.
UAA200614053A 2004-06-03 2005-06-03 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis UA87851C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57665204P 2004-06-03 2004-06-03

Publications (1)

Publication Number Publication Date
UA87851C2 true UA87851C2 (en) 2009-08-25

Family

ID=50633858

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200614053A UA87851C2 (en) 2004-06-03 2005-06-03 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Country Status (1)

Country Link
UA (1) UA87851C2 (en)

Similar Documents

Publication Publication Date Title
MY145077A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2006113864A3 (en) Oxindole compounds and their uses as therapeutic agents
TW200504053A (en) Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
TW200635588A (en) 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2007064931A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
TW200612926A (en) Compounds and compositions as ppar modulators
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
TW200602330A (en) Compounds and compositions as PPAR modulators
MXPA05009103A (en) 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders.
MX2007009356A (en) Compounds and compositions as ppar modulators.
WO2005046603A3 (en) Pyridine compounds
TW200628473A (en) Novel heterocycles
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
WO2007002884A3 (en) 4-fluoro-piperidine t-type calcium channel antagonists
ZA200706740B (en) Quinazolinone T-type calcium channel antagonists
WO2007002361A3 (en) 3-fluoro-piperidine t-type calcium channel antagonists
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
MX2010003269A (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase.